LONDON, April 1, 2014 /PRNewswire/ --
The US markets saw a positive sentiment on Monday, March 31, 2014, with the NASDAQ Composite
closing at 4,198.99, up 1.04%, the Dow Jones Industrial Average
ending the session at 16,457.66, up 0.82% and the S&P 500
edging 0.79% higher to finish the trading session at 1,872.34. The
gains were broad based as nine out of 10 sectors ended the session
in positive. A number of stocks saw large movements, including Teva
Pharmaceutical Industries Ltd (NYSE: TEVA), Capstone Turbine Corp.
(NASDAQ: CPST), Cigna Corp. (NYSE: CI) and Galena Biopharma Inc.
(NASDAQ: GALE). Free technical research on TEVA, CPST, CI and GALE
can be downloaded upon signing up at:
http://www.investor-edge.com/629-register
Shares in Teva Pharmaceutical Industries Ltd edged 6.86% higher,
finishing Monday's session at $52.84,
hitting a new 52-week high of $52.94.
The stock fluctuated between $49.60 and
$52.94 during the session with a trading volume of 13.63
million shares as compared to a three months average volume of 6.82
million shares. Shares in Teva Pharmaceutical Industries Ltd have
surged 8.10% in the previous three trading sessions, 5.91% in the
last one month, and 31.84% on YTD basis. The S&P 500 Health
Care Sector Index mapped a gain of 1.27% during the trading session
and charted up 5.40% in the previous three months. Furthermore, the
stock has a Relative Strength Index (RSI) of 56.70 and is trading
above its 50-day and 200-day moving averages of $47.01 and $41.25.
On the same day, Teva Pharmaceutical Industries Ltd announced that
the U.S. Supreme Court has granted its COPAXONE certiorari
petition and will hear its appeal of a decision from the United States Court of Appeals for the
Federal Circuit that invalidated the claim of U.S. Patent
5,800,808. Sign up today to read free research on TEVA at:
http://www.investor-edge.com/629-TEVA-01Apr2014.pdf
On Monday, shares in Capstone Turbine Corp. ended the session at
$2.13, up 5.97%. A total of 6.07
million shares were traded, as compared to a three months average
volume of 8.13 million shares. During the session, the stock traded
between $2.01 and $2.15. Capstone
Turbine Corp.'s shares have rallied 18.99% in the last one month,
65.12% in the previous three months and 65.12% on YTD basis. The
S&P 500 Industrials Sector Index mapped a gain of 1.03% during
the trading session and charted up 0.79% in the last one month.
Further, the stock has an RSI of 48.10 and is trading above its
50-day and 200-day moving averages of $1.84 and $1.40,
respectively. Sign up today to read free research on CPST at:
http://www.investor-edge.com/629-CPST-01Apr2014.pdf
Cigna Corp.'s stock finished Monday's session at $83.73, up 5.44%. A total of 5.91 million shares
were traded, which is above the three months average volume of 2.09
million shares. The stock vacillated between $80.13 and $84.28 during the session. Cigna
Corp.'s shares have advanced 4.66% in the previous three trading
sessions and 5.20% in the last one month. The company's shares
traded at a PE ratio of 12.36 and have fallen by 4.29% on YTD
basis. The S&P 500 Health Care Sector Index mapped a gain of
1.27% during the trading session, while the same has fallen by
1.37% in the last one month. Additionally, the stock has an RSI of
48.77 and is trading above its 50-day and 200-day moving averages
of $81.15 and $80.08, respectively. Sign up today to read free
research on CI at:
http://www.investor-edge.com/629-CI-01Apr2014.pdf
Shares in Galena Biopharma Inc. closed Monday's session at an
intra-day high of $2.50, which is
12.61% higher than the previous day's closing price of $2.22. A total of 6.15 million shares were traded
as compared to a three months average volume of 9.33 million
shares. The stock oscillated between $2.18
and $2.50 during the trading session. Shares in Galena
Biopharma Inc. have gained 4.60% in the previous three trading
sessions, while the same has declined 36.71% in the last one month
and 49.60% on YTD basis. The S&P 500 Health Care Sector Index
mapped a gain of 1.27% during the trading session and 0.74% in the
last three trading sessions. Moreover, the stock has an RSI of
27.15 and is trading below its 50-day and 200-day moving averages
of $4.15 and $3.12, respectively. Sign up today to read free
research on GALE at:
http://www.investor-edge.com/629-GALE-01Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and
our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by
our team, or wish to learn more about our services, please contact
us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
http://www.investor-edge.com/
SOURCE Investor-Edge